BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7586159)

  • 1. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
    Said TK; Luo L; Medina D
    Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development.
    Said TK; Medina D
    Carcinogenesis; 1995 Apr; 16(4):823-30. PubMed ID: 7728962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation in mouse mammary hyperplasias.
    Said TK; Medina D
    Carcinogenesis; 1995 Apr; 16(4):923-30. PubMed ID: 7728975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
    Said TK; Bonnette S; Medina D
    Cell Prolif; 1996 Nov; 29(11):623-39. PubMed ID: 9105418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
    Muraoka RS; Lenferink AE; Law B; Hamilton E; Brantley DM; Roebuck LR; Arteaga CL
    Mol Cell Biol; 2002 Apr; 22(7):2204-19. PubMed ID: 11884607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
    Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
    Chen B; Pollard JW
    Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
    Kong G; Chua SS; Yijun Y; Kittrell F; Moraes RC; Medina D; Said TK
    Oncogene; 2002 Oct; 21(47):7214-25. PubMed ID: 12370811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
    Sgambato A; Han EK; Zhang YJ; Moon RC; Santella RM; Weinstein IB
    Carcinogenesis; 1995 Sep; 16(9):2193-8. PubMed ID: 7554074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C; Shan L; Yu M; Snyderwine EG
    Cancer Res; 2003 Sep; 63(18):5674-8. PubMed ID: 14522882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.
    Zhang T; Nanney LB; Luongo C; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
    Cancer Res; 1997 Jan; 57(1):169-75. PubMed ID: 8988060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
    Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
    Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
    Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
    Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ; Li SA; Tawfik O; Li JJ
    Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.
    Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA
    Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.